Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

11.27 +0.08 (+0.71%)
Streaming Delayed Price Updated: 10:29 AM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 234,332
Open 11.12
Bid (Size) 11.25 (2)
Ask (Size) 11.28 (2)
Prev. Close 11.19
Today's Range 11.00 - 11.39
52wk Range 10.45 - 21.69
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
From Bausch + Lomb Corporation
Via Business Wire

Performance

YTD
-37.4%
-37.4%
1 Month
-6.5%
-6.5%
3 Month
-30.9%
-30.9%
6 Month
-41.8%
-41.8%
1 Year
-22.8%
-22.8%

More News

Read More
Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results
From Bausch + Lomb Corporation
Via Business Wire
Earnings Scheduled For April 30, 2025
Via Benzinga
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
From Bausch + Lomb Corporation
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
Via Benzinga
Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States
From Bausch + Lomb Corporation
Via Business Wire
BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty
Via StockStory
Topics World Trade
Exposures Tariff
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
From Pomerantz LLP
Via GlobeNewswire
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
3 Profitable Stocks Walking a Fine Line
Via StockStory
Topics Economy Supply Chain
Exposures Coal Supply Chain
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
From Bausch + Lomb Corporation
Via Business Wire
Why Bausch + Lomb (BLCO) Shares Are Falling Today
Via StockStory
Topics Initial Public Offering
Exposures Securities Market
Wednesday's session: gap up and gap down stocks
Via Chartmill
Starbucks Posts Weak Earnings, Joins Super Micro Computer, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Bausch + Lomb (NYSE:BLCO) Misses Q1 Sales Targets, Stock Drops 10.4%
Via StockStory
Bausch + Lomb Announces First-Quarter 2025 Results
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb (BLCO) Reports Q1: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics World Trade
Exposures Tariff
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall
From Bausch + Lomb Corporation
Via Business Wire
3 Reasons to Sell BLCO and 1 Stock to Buy Instead
Via StockStory
Topics Bankruptcy
Exposures Financial Legal

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 11.27
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 05/22/25 10:29 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.